NFE2L2 and amyotrophic lateral sclerosis: RTA-408, an activator of NRF2, reduces ferroptosis in hSOD1G93A NSC-34 cells and improves motor function of hSOD1G93A ALS mice, suggesting NRF2 as a potential therapeutic target for ALS.